Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy
- 30 September 2006
- journal article
- Published by Elsevier in Translational Research
- Vol. 148 (3), 120-127
- https://doi.org/10.1016/j.trsl.2006.04.006
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- A randomized trial of 24- vs. 48-week courses of PEG interferon α-2b plus ribavirin for genotype-1b-infected chronic hepatitis C patients: a pilot study in TaiwanLiver International, 2005
- Polymorphisms in the interferon-γ gene at position +874 in patients with chronic hepatitis C treated with high-dose interferon-α and ribavirinAntiviral Research, 2005
- Comparison of a 6‐month course peginterferon α‐2b plus ribavirin and interferon α‐2b plus ribavirin in treating Chinese patients with chronic hepatitis C in TaiwanJournal of Viral Hepatitis, 2005
- Randomized trial of three different regimens for 24 weeks for re-treatment of chronic hepatitis C patients who failed to respond to interferon-alpha monotherapy in TaiwanLiver International, 2004
- A prospective study on treatment of chronic hepatitis C with tailored and extended interferon-alpha regimens according to pretreatment virological factorsAntiviral Research, 2004
- Human Leukocyte Antigen Class I and II Alleles and Response to Interferon?? Treatment, in Taiwanese Patients with Chronic Hepatitis C Virus InfectionThe Journal of Infectious Diseases, 2003
- Optimal therapy of hepatitis CHepatology, 2002
- Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α TherapyScience, 1998
- Meta–Analysis of Interferon Randomized Trials in the Treatment of Viral Hepatitis C: Effects of Dose and DurationHepatology, 1996
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†Hepatology, 1981